Most Read Articles
5 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

3 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
5 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
3 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.

Thyroid stimulating hormone linked to risk of NALFD development, progression

29 Oct 2018

Thyroid-stimulating hormone (TSH) levels may be associated with the risk of nonalcoholic fatty liver disease (NAFLD) and its progression into nonalcoholic steatohepatitis (NASH), a recent meta-analysis has shown.

Twenty-six studies were eligible for inclusion corresponding to a cumulative sample size of 61,548 participants. Pooled analysis of 11 studies (n=47,217) showed that TSH levels were significantly higher in NAFLD patients than in healthy controls (weighted mean difference [WMD], 0105; 95 percent CI, 0.012–0.197; p=0.027). Heterogeneity of evidence was significant (p<0.001).

The effect of TSH on NAFLD remained significant even when healthy controls were compared to adults with euthyroidism alone (five studies; n=25,754; WMD, 0.100; 0.005–0.194; p=0.038). The same was true in lean (WMD, 1.039; 0.104–1.973) and overweight/obese (WMD, 0.485; 0.267–0.703; p<0.001) children regardless of thyroid function.

Similarly, the prevalence rate of unclassified hypothyroidism was significantly higher in adults with NAFLD than in healthy controls (odds ratio [OR], 1.605; 1.180–2.183; p=0.003).

Only one study (n=69) examined the potential effect of TSH on the progression of NAFLD. This found that NASH vs NAFLD patients had significantly elevated levels of TSH (WMD, 0.549; 0.136–0.944; p=0.009).

In terms of other biomarkers, there were no significant differences in concentrations of free and total thyroxine and triiodothyronine among healthy controls and adult NAFLD patients regardless of thyroid function. The prevalence of subclinical hypothyroidism was likewise statistically comparable between NAFLD patients and controls (OR, 1.251; 0.906–1.727; p=0.174).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

3 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
5 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
3 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.